Cytotoxic Necrotizing Factor 1 from Escherichia coli and Dermonecrotic Toxin from Bordetella bronchiseptica Induce p21rho-dependent Tyrosine Phosphorylation of Focal Adhesion Kinase and Paxillin in Swiss 3T3 Cells*

(Received for publication, December 23, 1996)

Hadriano M. Lacerda Dagger §, Gill D. Pullinger , Alistair J. Lax par and Enrique Rozengurt Dagger **

From the Dagger  Imperial Cancer Research Fund, P. O. Box 123, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom, the par  UMDS Guy's and St. Thomas's Medical and Dental School, Floor 28 Guy's Tower, Guy's Hospital, London SE1 9RT, United Kingdom, and the  Department of Chemical Endocrinology, St. Bartholomews Hospital Medical College, 51-53 Bartholomews Close, London EC1A 7BE, United Kingdom

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Treatment of Swiss 3T3 cells with cytotoxic necrotizing factor 1 (CNF1) from Escherichia coli and dermonecrotic toxin (DNT) from Bordetella bronchiseptica, which directly target and activate p21rho, stimulated tyrosine phosphorylation of focal adhesion kinase (p125fak) and paxillin. Tyrosine phosphorylation induced by CNF1 and DNT occurred after a pronounced lag period (2 h), and was blocked by either lysosomotrophic agents or incubation at 22 °C. CNF1 and DNT stimulated tyrosine phosphorylation of p125fak and paxillin, actin stress fiber formation, and focal adhesion assembly with similar kinetics. Cytochalasin D and high concentrations of platelet-derived growth factor disrupted the actin cytoskeleton and completely inhibited CNF1 and DNT induced tyrosine phosphorylation. Microinjection of Clostridium botulinum C3 exoenzyme which ADP-ribosylates and inactivates p21rho function, prevented tyrosine phosphorylation of focal adhesion proteins in response to either CNF1 or DNT. In addition, our results demonstrated that CNF1 and DNT do not induce protein kinase C activation, inositol phosphate formation, and Ca2+ mobilization. Moreover, CNF1 and DNT stimulated DNA synthesis without activation of p42mapk and p44mapk providing additional evidence for a novel p21rho-dependent signaling pathway that leads to entry into the S phase of the cell cycle in Swiss 3T3.


INTRODUCTION

An increase in the tyrosine phosphorylation of the non-receptor protein tyrosine kinase p125fak (1, 2) and the cytoskeletal associated protein paxillin (3, 4) has recently been identified as an early event in the action of diverse signaling molecules that mediate cell growth and differentiation (5), including mitogenic neuropeptides (6-8), growth factors such as PDGF1 (9, 10), bioactive lipids (11-15), extracellular matrix proteins (16-20), transforming variants of pp60src (17, 21), and the potent mitogenic toxin PMT (22). p125fak lacks SH2 and SH3 domains but associates with other proteins including Src, paxillin, and p130cas (1, 2, 23). Paxillin is a multidomain protein that may function as an adaptor capable of complex formation with p125fak, Crk, Src, and vinculin (3, 4, 23). Gene disruption experiments indicate a critical role of p125fak in embryonic development and cell locomotion (24). The increases in p125fak and paxillin tyrosine phosphorylation are accompanied by profound alterations in the organization of the actin cytoskeleton and in the assembly of focal adhesions (9, 13, 15, 25, 26), the distinct areas of the plasma membrane where p125fak and paxillin are localized (1, 2, 27). The small G protein p21rho, a member of the Ras superfamily of small GTP-binding proteins, has been implicated in the mitogen-stimulated formation of focal adhesions and actin stress fibers as well as in the tyrosine phosphorylation of p125fak and paxillin (22, 25, 28-30). These findings suggest the existence of a distinct signal transduction pathway in which p21rho is upstream of cytoskeletal reorganization and tyrosine phosphorylation of focal adhesion proteins (5).

The mechanism of action of bacterial toxins has provided novel insights into the control of cellular regulatory processes, including signal transduction and cell proliferation. For example, the Clostridium botulinum C3 exoenzyme and the enterotoxins A and B from Clostridium difficile which selectively inactivate members of the Rho subfamily, have provided useful tools to evaluate the role of these small G proteins in signal transduction and cytoskeletal organization (31-33). In contrast to these clostridial toxins, CNF toxins produced by some pathogenic strains of Escherichia coli (34) and DNT from Bordetella bronchiseptica (35) directly target and activate p21rho (36, 37). CNF and DNT induce actin reorganization and multinucleation in several cell types (37-40) but their effects on signal transduction pathways, specially on p125fak and paxillin tyrosine phosphorylation have not been examined.

Here we report that CNF1 and DNT stimulate tyrosine phosphorylation of p125fak and paxillin and induce a concomitant increase in the formation of actin stress fibers and in the assembly of focal adhesion plaques in Swiss 3T3 cells. Microinjection of C3 exoenzyme prevented both the cytoskeletal responses and the increase in tyrosine phosphorylation of focal adhesion proteins. In contrast to most other stimuli that promote tyrosine phosphorylation of p125fak and paxillin (6-15, 22), CNF1 and DNT do not activate phospholipase C-mediated events including inositol phosphate production, Ca2+ mobilization, and PKC activation. In addition, CNF1 and DNT both stimulated reinitiation of DNA synthesis but neither induce activation of p42mapk (ERK2). Thus, our results demonstrating that CNF1 and DNT induce a specific subset of molecular and cytoskeletal responses in Swiss 3T3 cells provide novel evidence for the existence of a signal transduction pathway that links p21rho activation to tyrosine phosphorylation of focal adhesion proteins.


EXPERIMENTAL PROCEDURES

Cell Culture

Stock cultures of Swiss 3T3 fibroblasts were maintained in DMEM supplemented with 10% fetal bovine serum in a humidified atmosphere containing 10% CO2 and 90% air at 37 °C. For experimental purposes, cells were plated either in 30-mm Nunc Petri dishes at 105 cells/dish, or in 90-mm dishes at 6 × 105 cells/dish, in DMEM containing 10% fetal bovine serum and used after 6-8 days when the cells were confluent and quiescent (41).

DNA Synthesis Measurements

Quiescent cultures of Swiss 3T3 cells were washed twice with DMEM and incubated with DMEM/Waymouth's medium 1:1 (v/v) containing [3H]thymidine (1 µCi/ml) and various factors as indicated. After 40 h, the cultures were washed twice with ice-cold phosphate-buffered saline and incubated in 5% trichloroacetic acid for 30 min at 4 °C. Trichloroacetic acid was then removed and the cultures were washed twice with ethanol and extracted in 1 ml of 2% Na2CO3, 0.1 M NaOH, 1% SDS. Incorporation of [3H]thymidine was determined by scintillation counting in 6 ml of scintillation fluid. The proportion of cells in the G0/G1, S, G2, and M phases of the cell cycle were determined by fluorescence-activated cell sorter analysis as described previously (42).

Immunoprecipitation

Quiescent cultures of Swiss 3T3 cells (1-2 × 106) were washed twice with DMEM, treated with CNF1, DNT, or PMT or other factors in 10 ml of DMEM/Waymouth (1:1, v/v) for the times indicated and lysed at 4 °C in 1 ml of a lysis buffer solution containing 10 mM Tris/HCl, pH 7.6, 5 mM EDTA, 50 mM NaCl, 30 mM sodium pyrophosphate, 50 mM sodium fluoride, 100 µM Na3VO4, and 1% Triton X-100. Proteins were immunoprecipitated at 4 °C overnight with agarose-linked mAbs directed against phosphotyrosine, paxillin, or p125fak as indicated. Immunoprecipitates were washed three times with lysis buffer and extracted for 10 min at 95 °C in 2 × SDS-PAGE sample buffer (200 mM Tris-HCl, 6% SDS, 2 mM EDTA, 4% 2-mercaptoethanol, 10% glycerol, pH 6.8) and analyzed by SDS-PAGE.

Western Blotting

Treatment of quiescent cultures of cells with factors, cell lysis, and immunoprecipitations were performed as described above. After separation by SDS-PAGE, proteins were transferred to Immobilon membranes (43). Membranes were blocked using 5% nonfat dried milk in PBS, pH 7.2, and incubated for 3-5 h at 22 °C with PY72 or 4G10 anti-Tyr(P) mAbs (1 µg/ml). Immunoreactive bands were visualized using 125I-labeled sheep anti-mouse IgG followed by autoradiography. Autoradiograms were scanned using an LKB Ultrascan XL internal integrator. The values expressed represent percentages of the maximum increase in tyrosine phosphorylation above control values.

32P Labeling of Cells and Analysis of 80K/MARCKS Phosphorylation

Quiescent and confluent cultures of Swiss 3T3 cells in 30-mm dishes were washed twice in phosphate-free DMEM and incubated at 37 °C with this medium containing 50 µCi/ml carrier-free [32P]Pi. After 12 h, various factors were added for the indicated times. The cells were subsequently lysed and the lysates were immunoprecipitated with specific anti-80K/MARCKS antibody (44).

Analysis of Total Inositol Phosphates

Cultures of Swiss 3T3 cells in 33-mm dishes were labeled for 16-18 h in 1 ml of DMEM/Waymouth's medium (1:1) containing 10 µCi of [2-3H]inositol. Additions were made to the cells as described for each experiment and LiCl was added to a final concentration of 20 mM for the last 30 min of the incubation. Inositol phosphates were extracted by replacing the medium with 1 ml of ice-cold 3% HClO4. After 20 min at 4 °C the extract was neutralized with 0.5 M KOH containing 25 mM HEPES, 5 mM EDTA, and 0.01% phenol red. Precipitated KClO4 was removed by centrifugation. Analysis of total inositol phosphates was by anion-exchange column chromatography (45). Samples were diluted to 10 ml with water and then loaded onto 1 ml of Dowex AG1-X8 (100-200 mesh, HCOO- form) in Bio-Rad Econo-columns. After 3 washes with 3 × 10 ml of H2O and 2 × 10 ml of 60 mM NH4COOH, 5 mM Na2B4O7 the inositol phosphates were eluted with 7 ml of 1 M NH4COOH, 0.1 M HCOOH. An aliquot (1 ml) of eluate was counted in 10 ml of scintillation fluid.

Intracellular Concentration of Ca2+

To determine the intracellular concentration of Ca2+, [Ca2+]i, 5 × 105 cells were subcultured with 10 ml of DMEM containing 10% fetal bovine serum in 90-mm Nunc dishes. After 6-8 days, when the cells were confluent and quiescent, the medium was replaced with 5 ml of DMEM/Waymouth's medium (1:1). The cells were pretreated as indicated, and then 5 µl of 1 mM fura-2/AM (46-48) was added directly to the medium. After a further 10 min the cells were washed twice at 37 °C with 3 ml of electrolyte solution, comprising 140 mM NaCl, 5 mM KCl, 1.8 mM CaCl2, 0.9 mM MgCl2, 25 mM glucose, 16 mM HEPES, 6 mM Tris, pH 7.2, and the amino acid content of DMEM. The cells were then gently removed from the dish by scraping into 2 ml of the electrolyte solution. The cell suspension was transferred to a 1-cm2 quartz cuvette and stirred at 37 °C for 4 min prior to any additions. Fluorescence was measured in a Perkin-Elmer LS-5 fluorometer with an excitation wavelength of 510 nm. [Ca2+]i was calculated from the maximum and minimum fluorescence of the fura-2, as described (46, 49).

Immunostaining of Cells

Quiescent Swiss 3T3 cells were washed twice with DMEM and incubated for the indicated times in DMEM/Waymouth's medium (1:1, v/v) at 37 °C with CNF1, DNT, or PMT. For actin staining, cells were washed once with PBS, fixed in 4% paraformaldehyde in PBS for 10 min at room temperature, and permeabilized with PBS containing 0.2% Triton X-100 for 8 min at room temperature. The cells were then incubated with FITC-conjugated phalloidin (0.25 µg/ml) in PBS for 30 min at room temperature and visualized using a Zeiss Axiophot immunofluorescence microscope. In experiments in which quiescent Swiss 3T3 cells were labeled with both FITC-conjugated phalloidin and anti-vinculin antibody, the cells were fixed and permeabilized as described above and then stained with a mixture of FITC-conjugated phalloidin (0.25 µg/ml) and anti-vinculin antibody (dilution 1:100) for 30 min at room temperature. Cells were subsequently washed three times in PBS and then incubated with Cy3-labeled rabbit anti-mouse IgG as a secondary antibody at a dilution of 1:100 for another 30 min at room temperature.

Microinjection of C3 Exoenzyme

For microinjection experiments Swiss 3T3 cells were plated in 33-mm Nunc Petri dishes at 105 cells/dish in DMEM containing 10% fetal bovine serum and used after 6-8 days when the cells were confluent and quiescent. Approximately 50 cells were microinjected with 100 µg/ml recombinant C3 exoenzyme. The efficiency of injection was determined by co-injecting guinea pig immunoglobulin at 0.5 mg/ml followed by staining with FITC-linked goat anti-guinea pig IgG. A single batch of C3 transferase was used in all experiments described.

Confocal Microscopy

Confocal imaging was performed using a Bio-Rad MRC 600 laser scanning head fitted to a Nikon Optiphot microscope. A 60X N.A./1.4 planapochromat oil immersion lens (Nikon) was used for all imaging. FITC-conjugated phalloidin and Cy3 anti-mouse IgG fluorochromes were excited at 488 and 568 nm, respectively, using a krypton/argon mixed gas laser (Bio-Rad). Two filter blocks were used, K1 and K2. K1 is a double dichromic filter enabling excitation at the wavelengths of 488 and 568 nm, whereas the K2 filter is a 560-nm dichromic combined with 522-nm green emission and 585-nm red emission filters. Images were collected using the Kalman filter. Care was taken to ensure that the FITC-conjugated phalloidin channel was sufficiently bright relative to the fluorescein signal to minimize the contribution of bleed-through from the green channel into the red channel (approximately 10%). Correction of images for bleed-through and other processing was carried out using COMOS and SOM programs (Bio-Rad) run on a Compaq Deskpro 66M 486 computer (66 MHz). Data are presented as projections of sequential optical sections. For Z-series, optical sections were recorded at 0.5-µm intervals. Final images were photographed directly from the VDU screen.

Shift Assay for MAP Kinase Activation

Activation of p42mapk and p44mapk was determined by the appearance of slower migrating forms in gel electrophoresis due to phosphorylation of specific threonine and tyrosine residues (50). Lysates from quiescent cells in 33-mm dishes prepared as above were subjected to SDS-PAGE and transferred to Immobilon membranes. Membranes were blocked using 5% nonfat dried milk in phosphate-buffered saline. Rabbit polyclonal antibodies raised against COOH-terminal peptides (EETARFQPGYRS for p42mapk and IFQETARFQPGAPE for the p44mapk) were used at 1/1000 dilution, and 125I-protein A was used to visualize immunoreactive bands.

Constructs Bearing CNF1, DNT, and PMT

Strain pISS392 is E. coli DH5alpha containing plasmid pISS392 which consists of a 3.5-kilobase fragment encoding only CNF1 inserted into the vector pGEM3. Control strain pGEM3 is E. coli DH5alpha containing a plasmid derived from pISS392 by deletion of a 3.5-kilobase insert. It is pGEM3 with a deletion in the multiple cloning site. Strain DNT1 is E. coli XL1-Blue containing plasmid pDNT1 which consists of a 5-kilobase fragment encoding the DNT gene (B. bronchiseptica B58) inserted into the vector pBluescript. Control strain pBlue is E. coli XL1-Blue with plasmid pBluescript (51). Strain pTOX2 is E. coli XL1-Blue with plasmid pTOX2 which consists of the vector pBluescript with an approximately 4-kilobase pair insert encoding PMT. Control strain pBlue is E. coli XL1-Blue with plasmid pBluescript here nominated PC12.

Preparation of Samples of CNF1, DNT, and PMT

The E. coli strains were grown overnight from a fresh colony. They were lysed in the lysis buffer (50 µg/ml lysozyme, 5 mM EDTA, 0.1% toluene, 0.05 M Tris-Cl, pH 7.2, 0.1 M NaCl) treated with RNase and DNase at 10 µg/ml each to remove nucleic acid and filtered through a 0.2-µm nitrocellulose filter.

Materials

Bombesin, cytochalasin D, FITC-conjugated phalloidin, monoclonal anti-vinculin mAb, Cy3-linked anti-mouse IgG, guinea pig IgG, and FITC-conjugated goat anti-guinea pig IgG were obtained from Sigma. Recombinant PDGF (BB homodimer), 125I-sheep anti-mouse IgG (15 mCi/mg), carrier-free [32P]Pi, and [2-3H]inositol (18.8 Ci/mmol, 1 Ci = 37 GBq) were all supplied by Amersham Corp., United Kingdom. Agarose-linked anti-Tyr(P) mAb was purchased from Oncogene Science Inc., New York. 4G10 anti-Tyr(P) mAb was from UBI, Lake Placid, NY. mAb 2A7 directed against p125fak was from TCS Biologicals Ltd., Buckingham, United Kingdom. p125fak immunoblotting was performed with mAb from Transduction Laboratories, Lexington, KY. The anti-Tyr(P) mAb PY72 was obtained from the hybridoma development unit, Imperial Cancer Research Fund. Clone pISS392 was kindly supplied by Dr. A. Caprioli, Instituto Superiore di Sanita, Rome, Italy. All other reagents were of the highest grade commercially available. The C3 C. botulinum exoenzyme was a gift from Dr. N. Morii and Professor S. Narumiya, Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo-ku 606, Japan.


RESULTS

CNF1 Stimulates Tyrosine Phosphorylation of p125fak and Paxillin in Swiss 3T3 Cells

To examine the effects of CNF1 on tyrosine phosphorylation, quiescent cultures of Swiss 3T3 cells were treated with the control bacterial lysate (pGEM3) or with lysate containing CNF1 for 6 h. Cell extracts were immunoprecipitated with anti-Tyr(P) mAb followed by Western blotting with an anti-Tyr(P) mAb. As shown in Fig. 1A, CNF1 markedly stimulated the tyrosine phosphorylation of a group of bands migrating with an apparent Mr of 110,000-130,000 and 70,000-80,000.


Fig. 1. CNF1 induces tyrosine phosphorylation of multiple bands including p125fak and paxillin in Swiss 3T3 cells. A, quiescent cultures of Swiss 3T3 cells were treated in DMEM/Waymouth's medium (1:1, v/v) with (-) 5 µg/ml control bacterial lysate (pGEM3) or with (+) 5 µg/ml bacterial lysate containing CNF1 for 6 h. Cells were lysed and the lysates were immunoprecipitated with agarose-linked anti-Tyr(P) mAb, anti-p125fak mAb 2A7, or anti-paxillin mAb 165. The immunoprecipitates were fractionated by SDS-PAGE and further analyzed by immunoblotting with a mixture of anti-Tyr(P) mAbs. B, quiescent cultures of Swiss 3T3 cells were treated in DMEM/Waymouth's medium (1:1, v/v) with 5 µg/ml bacterial lysate containing CNF1 for various times (0-24 h) as indicated. Cells were lysed and the lysates were immunoprecipitated using anti-p125fak mAb 2A7 or anti-paxillin mAb and analyzed by immunoblotting with a mixture of anti-Tyr(P) mAbs (upper and lower autoradiograms). Immunoblotting with p125fak mAb of anti-p125fak immunoprecipitates verified that similar amounts of p125fak were recovered after different times of CNF1 treatment (middle autoradiogram). The positions of p125fak and paxillin are indicated by arrowheads. The plot shows the values of the mean of three independent experiments which are expressed as the percentage of the maximum stimulation of tyrosine phosphorylation of p125fak band at the indicated times quantified by scanning densitometry. C, quiescent cultures of Swiss 3T3 cells were incubated for 6 h in DMEM/Waymouth's (1:1, v/v) medium containing 5 µg/ml bacterial lysate containing CNF1 with or without 10 mM CH3NH2 or incubated at 22 °C. Cells were lysed and the lysates immunoprecipitated with anti-Tyr(P) mAb or anti-p125fak mAb 2A7. The immunoprecipitates were fractionated by SDS-PAGE and further analyzed by anti-Tyr(P) immunoblotting. The results shown in this and subsequent figures are representative autoradiographs of at least three independent experiments.
[View Larger Version of this Image (35K GIF file)]


The pattern of tyrosine-phosphorylated proteins induced by CNF1 is similar to that stimulated by bombesin, bioactive lipids, and PMT in Swiss 3T3 cells (8, 13, 15, 22). The cytosolic tyrosine kinase p125fak and the adaptor protein paxillin have been identified as prominent tyrosine-phosphorylated proteins in Swiss 3T3 cells treated with these agents. To determine whether these cellular proteins were also substrates for CNF1-induced tyrosine phosphorylation, extracts from Swiss 3T3 cells, incubated with the control bacterial lysate (pGEM3) or CNF1 for 6 h, were immunoprecipitated with mAbs that recognize either p125fak or paxillin, and the immunoprecipitates were analyzed by Western blotting with anti-Tyr(P) mAb. As shown in Fig. 1A, CNF1 markedly stimulated tyrosine phosphorylation of p125fak and paxillin in Swiss 3T3 cells. The control bacterial lysate (pGEM3) did not stimulate tyrosine phosphorylation of these bands or of any other protein (data not shown).

CNF1 Enters the Cell to Transiently Stimulate Tyrosine Phosphorylation of p125fak and Paxillin

Neuropeptides and lysophosphatidic acid induce tyrosine phosphorylation of p125fak and paxillin within minutes of treatment (6, 8, 13), whereas there is a lag period of 1 h between the addition of PMT and a detectable increase in tyrosine phosphorylation of these proteins (22). As shown in Fig. 1B, CNF1-stimulated tyrosine phosphorylation of p125fak and paxillin occurred after a lag period of 2 h, reached a maximum after 8 h of treatment and declined to 56% ± 9.5 (mean ± S.E.) of the maximum after 24 h. This is in contrast to the tyrosine phosphorylation of p125fak and paxillin stimulated by PMT which remains maximal after 24 h of treatment (data not shown). Immunoblotting with p125fak mAb of anti-p125fak immunoprecipitates prepared in parallel with those used for the assays of tyrosine phosphorylation verified that similar amounts of p125fak were recovered after different times of CNF1 treatment (Fig. 1B).

Next we examined whether the lag period in CNF1 action reflects a requirement for internalization and activation of the toxin during transit through endosomal/lysosomal compartments. The lysosomotrophic agent methylamine, a membrane-permeant weak base known to inhibit lysosomal processing, completely blocked tyrosine phosphorylation of the Mr 110,000-130,000 and Mr 70,000-80,000 bands in response to CNF1 (Fig. 1C). Methylamine also prevented the increase in tyrosine phosphorylation of p125fak in response to CNF1 (Fig. 1C). The inhibitory effect of methylamine was selective because it did not prevent the increase in tyrosine phosphorylation induced by bombesin in parallel cultures (data not shown). It is also known that the entry of many bacterial toxins into the cell cytoplasm is temperature-dependent. Treatment of Swiss 3T3 cells with CNF1 for 6 h at 22 °C failed to induce tyrosine phosphorylation (Fig. 1C). In contrast, bombesin stimulated tyrosine phosphorylation of Mr 110,000-130,000 and Mr 70,000-80,000 bands in parallel cultures incubated at 22 °C (data not shown). Therefore, CNF1 appears to enter cells via an endosomal/lysosomal pathway where it is processed and released into the cytosol in an active form to stimulate tyrosine phosphorylation of p125fak and paxillin.

CNF1 Transiently Induces Actin Stress Fiber Formation and Focal Contact Assembly

Given the localization of p125fak and paxillin to focal contacts which form at the end of actin stress fibers we examined the kinetics of actin cytoskeleton reorganization and focal adhesion assembly induced by CNF1. As shown in Fig. 2, CNF1 treatment of Swiss 3T3 cells induced the formation of new actin stress fibers after a 2-h lag period. Actin reorganization reached a maximum after 8 h of exposure to CNF1. Interestingly, after 24 h of CNF1 treatment, the number of actin stress fibers decreased and actin appeared to accumulate in a cortical fashion. Vinculin staining showed the recruitment of this protein to focal adhesions formed at the ends of actin stress fibers. The number of focal adhesions also reached a maximum after 8 h and decreased after 24 h treatment (Fig. 2). The control bacterial lysate did not induce actin stress fiber formation or focal adhesion assembly (2-24 h, data not shown).


Fig. 2. Effect of CNF1 on the actin cytoskeleton and focal contacts. Quiescent cultures of Swiss 3T3 cells were washed with DMEM and incubated in DMEM/Waymouth's medium (1:1, v/v) containing 5 µg/ml lysate containing CNF1 for the times indicated, and then washed with PBS, fixed in 3.7% paraformaldehyde, and permeabilized with 0.2% Triton X-100. A double labeling technique with FITC-conjugated phalloidin and the monoclonal anti-vinculin antibody was used to compare the concomitant changes in the formation of stress fibers with those of vinculin at the focal adhesions (left and right, respectively). Confocal imaging was performed as described under "Experimental Procedures."
[View Larger Version of this Image (91K GIF file)]


CNF1-stimulated Tyrosine Phosphorylation Requires Integrity of the Actin Cytoskeleton and Functional p21rho

The time-dependent effects of CNF1 on actin stress fiber formation and focal adhesion assembly depicted in Fig. 2 prompted us to examine whether the integrity of the actin cytoskeleton was necessary for CNF1-induced tyrosine phosphorylation. Quiescent cultures of Swiss 3T3 cells were pretreated with 1.2 µM cytochalasin D for 1 h and then stimulated with CNF1 for 6 h. As shown in Fig. 3, cytochalasin D prevented the assembly of focal adhesions (upper panel C) and completely blocked tyrosine phosphorylation of p125fak (middle panel) and paxillin (data not shown) in response to CNF1.


Fig. 3. Effect of cytochalasin D, PDGF, and C3 exoenzyme on CNF1-stimulated tyrosine phosphorylation and focal adhesion assembly. Upper panel, effect of cytochalasin D and PDGF on CNF1-stimulated focal adhesion assembly. Cells were treated with (A) 5 µg/ml control bacterial lysate (pGEM3) for 4 h, (B) 5 µg/ml of bacterial lysate containing CNF1 for 4 h, (C) 1.2 µM cytochalasin D (CYT.D) for 1 h and subsequently with 5 µg/ml bacterial lysate containing CNF1 for 4 h, or (D) 5 µg/ml bacterial lysate containing CNF1 for 4 h and 30 ng/ml PDGF for a further 10 min. Cells were then washed with PBS and fixed in 4% paraformaldehyde, permeabilized, and focal adhesion were then visualized with mouse anti-vinculin mAb and Cy3-conjugated rabbit anti-mouse IgG. Middle panel, effect of cytochalasin D and PDGF on CNF1 stimulated p125fak tyrosine phosphorylation. Quiescent Swiss 3T3 cells were treated with (-) 5 µg/ml of the control bacterial lysate (pGEM3) or treated with 1.2 µM cytochalasin D for 1 h and then incubated with 5 µg/ml bacterial lysate containing CNF1 for a further 4 h. Parallel cell cultures were treated with 5 µg/ml bacterial lysate containing CNF1 for 4 h and subsequently with 30 ng/ml PDGF for a further 10 min. Cells were then lysed, and the lysates were further analyzed by immunoprecipitation using mAb 2A7 directed against p125fak followed by anti-Tyr(P) Western blotting. Lower panel, microinjection of C3 exoenzyme prevents the increase of tyrosine phosphorylation of focal adhesion proteins. Quiescent cultures of Swiss 3T3 cells in 30-mm dishes were washed twice and incubated in DMEM/Waymouth's medium (1:1, v/v). Cells were microinjected with 0.5 mg/ml guinea pig IgG (A and B) or 0.5 mg/ml guinea pig IgG + 100 µg/ml C3 exoenzyme (C and D). Cells were then treated with 5 µg/ml bacterial lysate containing CNF1. After 4 h of incubation, the cells were stained with 4G10 mAb directed against phosphotyrosine residues and visualized by confocal microscopy using Cy3-linked rabbit anti-mouse IgG (B and D). Microinjected cells (shown in A and C) were identified by staining with FITC-conjugated goat anti-guinea pig IgG Ab.
[View Larger Version of this Image (57K GIF file)]


Recent data from our laboratory have shown that PDGF, at a high concentration (30 ng/ml), completely abolishes bombesin-, lysophosphatidic acid-, and PMT-induced actin stress fiber formation and focal adhesions assembly. Similarly, the marked increase in focal adhesion assembly and actin stress fibers induced by CNF1 was prevented by the addition of PDGF at 30 ng/ml (Fig. 3, upper panel D, and results not shown). Since CNF1 stimulated p125fak tyrosine phosphorylation by a mechanism dependent on the integrity of the actin cytoskeleton, we examined whether CNF1-stimulated tyrosine phosphorylation of p125fak could be affected by high concentrations of PDGF. As shown in Fig. 3 (middle panel), PDGF (30 ng/ml) markedly reduced CNF1-stimulated tyrosine phosphorylation of p125fak.

The rho gene product, p21rho, has been implicated in the assembly of focal adhesions and in tyrosine phosphorylation of p125fak and paxillin (9, 25, 29, 30). It has been suggested that CNF1 directly targets and activates p21rho (36, 52). To investigate the role of p21rho in the CNF1-stimulated tyrosine phosphorylation of focal adhesion-associated proteins we utilized the C. botulinum C3 exoenzyme which ADP-ribosylates Asn41 of p21rho and thereby prevents its function (53-55). Recombinant C3 exoenzyme and pure guinea pig IgG were comicroinjected into confluent and quiescent Swiss 3T3 cells, and the cultures were further treated with CNF1 for 4 h. Cells were then fixed, permeabilized, and stained for tyrosine-phosphorylated proteins which are predominantly localized at the focal contacts in CNF1-treated cells (Fig. 3, lower panel B). The tyrosine phosphorylation of focal adhesion proteins in response to CNF1 was profoundly inhibited in cells microinjected with C3 exoenzyme (Fig. 3, lower panel D). Microinjection itself did not interfere with CNF1-induced tyrosine phosphorylation of focal adhesion proteins (Fig. 3, lower panels A and B).

CNF1, Unlike PMT, Does Not Induce PKC Activation, Inositol Phosphate Formation, Ca2+ Mobilization, or MAPK Activation

PKC activation is a potential signal transduction pathway leading to increased tyrosine phosphorylation of p125fak and paxillin (8). As the effect of CNF1 on PKC activation was unknown, we tested whether CNF1 induces phosphorylation of 80K/MARCKS, a major PKC substrate in Swiss 3T3 cells. Cells labeled with [32P]Pi were treated with CNF1 for 6 h and lysed. The lysates were incubated with an anti-80K/MARCKS rabbit polyclonal antibody and the immunoprecipitates were analyzed by SDS-PAGE. As shown in Fig. 4A, CNF1 did not stimulate 80K/MARCKS phosphorylation. In contrast, addition of a bacterial lysate containing PMT to parallel cultures induced 80K/MARCKS phosphorylation, in agreement with previous results (56).


Fig. 4. CNF1 does not induce PKC activation, inositol phosphate production, Ca2+ mobilization, or p42mapk/p44mapk activation. A, quiescent cells, labeled with 50 µCi/ml [32P]Pi for 18 h, were treated with 5 µg/ml control bacterial lysate (pGEM3), 5 µg/ml bacterial lysate containing CNF1, 2 µg/ml control bacterial lysate (PC12), or 2 µg/ml bacterial lysate containing PMT and incubated for further 6 h. Cells were subsequently lysed and the lysates were immunoprecipitated with anti-80K/MARCKS antibody and further analyzed by SDS-PAGE. B, cells were prelabeled with 10 µCi/ml [2-3H]inositol for 16 h treated with the same conditions as described above adding directly to the dishes and the cultures were incubated at 37 °C for 6 h. LiCl (20 mM) was then added, and after a further 30 min the cellular inositol phosphate content was determined. C, [Ca2+]i was measured as described under "Experimental Procedures." Quiescent cells were pretreated with 5 µg/ml control bacterial lysate (pGEM3), 5 µg/ml bacterial lysate containing CNF1, 2 µg/ml control bacterial lysate (PC12), or 2 µg/ml bacterial lysate containing PMT for 4 h, and the increase in [Ca2+]i induced by bombesin (10 nM) was then determined. D, quiescent cells were treated for 4 h as described above and lysed. The cell extracts were subjected to SDS-PAGE, followed by Western blotting with anti-p42mapk/p44mapk antibody.
[View Larger Version of this Image (24K GIF file)]


To substantiate that CNF1 does not activate a phospholipase C-dependent pathway that leads to the production of the intracellular second messengers diacylglycerol and Ins(1,4,5)P3, we determined the effect of CNF1 on the production of total inositol phosphates. Quiescent cultures of Swiss 3T3 cells labeled with [2-3H]inositol were incubated with the control bacterial lysate (pGEM3) or with lysate containing CNF1 for 6 h. Fig. 4B shows that CNF1 did not stimulate a detectable increase in total inositol phosphate production. In contrast, PMT potently induced the formation of inositol phosphates in parallel cultures of Swiss 3T3 cells.

Prolonged incubation of cells with PMT depletes Ca2+ from intracellular stores and thereby prevents Ca2+ release by subsequent addition of bombesin (57). To examine whether CNF1 reduces the Ins(1,4,5)P3-sensitive Ca2+ pool in Swiss 3T3 cells, quiescent cultures of these cells were treated with CNF1 or PMT for 4 h, loaded with fura-2-tetraacetoxymethyl ester, and stimulated with 10 nM bombesin. As shown in Fig. 4C, treatment with CNF1 did not reduce the Ca2+ mobilization induced by subsequent addition of bombesin. In contrast, PMT in parallel cultures caused a dramatic reduction of bombesin-mediated Ca2+ mobilization. We conclude that CNF1 stimulates tyrosine phosphorylation through a phospholipase C- and PKC-independent pathway.

Several mitogens stimulate rapid and transient activation of p42mapk and p44mapk through various signal transduction pathways including Ca2+ mobilization and PKC activation (58, 59). A significant property of MAPKs activation is the requirement for both Thr and Tyr phosphorylation within its protein kinase subdomain VIII, resulting in a mobility shift in SDS-PAGE gels. To determine if CNF1 induces p42mapk and p44mapk activation, lysates of Swiss 3T3 stimulated for various times with control bacterial lysate (pGEM3), CNF1, or PMT were analyzed by Western blotting with anti-p42mapk/p44mapk antibody. Only PMT induced p42mapk and p44mapk activation as judged by the appearance of slower migrating forms of p42mapk and p44mapk (Fig. 4D). We verified that CNF1 failed to stimulate p42mapk and p44mapk activation after various times of incubation (2-6 h).

The striking differences between the early events induced by CNF1 and PMT in Swiss 3T3 cells prompted us to examine the effect of CNF1 on DNA synthesis in these cells. Quiescent cultures of Swiss 3T3 cells were transferred to serum-free medium containing various concentrations of the control bacterial lysate (pGEM3) or CNF1. Cumulative [3H]thymidine incorporation was measured after 40 h. As shown in Fig. 5A, CNF1 induced DNA synthesis in a dose-dependent manner whereas the control bacterial lysate (pGEM3) did not induce any measurable increase in [3H]thymidine incorporation in parallel cell cultures. Insulin potentiated the mitogenic effect of CNF1. The maximum levels of DNA synthesis induced by the combination of CNF1 and insulin were similar to those stimulated by medium containing 10% (v/v) fetal bovine serum. Methylamine (10 mM) profoundly inhibited the stimulation of DNA synthesis induced by CNF1 and insulin. Fluorescence-activated cell sorter analysis confirmed that CNF1 stimulated DNA synthesis and induced multinucleation in Swiss 3T3 cells, as described in other cell types (data not shown).


Fig. 5. Stimulation of DNA synthesis in Swiss 3T3 cells by CNF1 and DNT. Dose-response curve for the stimulation of DNA synthesis by CNF1 (A) and DNT (B). Confluent, quiescent cultures of Swiss 3T3 cells were washed and incubated at 37 °C in 2 ml of Dulbecco's modified Eagle's medium DMEM/Waymouth's medium (1:1, v/v), containing 1 µCi of [3H]thymidine/ml. In panel A, cultures received various concentrations of the control bacterial lysate (black-triangle) (pGEM3), bacterial lysate containing CNF1 (open circle ), bacterial lysate containing CNF1 and 1 µg/ml insulin (bullet ), or bacterial lysate containing CNF1, 1 µg/ml insulin, and 10 mM CH3NH2 (square ). In panel B, cultures received control bacterial lysate XL1Blue (black-triangle), bacterial lysate containing DNT (open circle ), bacterial lysate containing DNT and 1 µg/ml insulin (bullet ), or bacterial lysate containing DNT, 1 µg of insulin, and 10 mM CH3NH2 (square ). After 40 h, DNA synthesis was assessed by measuring the level of [3H]thymidine incorporated into half of the acid-precipitable material. Each point is the mean determination from three independent experiments.
[View Larger Version of this Image (19K GIF file)]


DNT Stimulates p125fak and Paxillin Tyrosine Phosphorylation in a p21rho-dependent Fashion

Recently, DNT from B. bronchiseptica has been show to directly target and activate p21rho (37). As shown in Fig. 5B, DNT also promotes DNA synthesis in Swiss 3T3 cells. Consequently, we examined whether DNT stimulates a pattern of early events comparable to that induced by CNF1. As shown in Fig. 6, treatment of Swiss 3T3 cells with a bacterial lysate containing DNT stimulated tyrosine phosphorylation of p125fak and paxillin (upper panel) with similar kinetics to stress fiber formation (data not shown) and focal adhesion assembly (lower panel). The observed lag period suggests that internalization and processing of the toxin in the endosomal/lysosomal compartment is required. Indeed, addition of 10 mM methylamine to the culture medium or reduction of the temperature to 22 °C inhibited DNT-stimulated tyrosine phosphorylation (data not shown).


Fig. 6. DNT induces tyrosine phosphorylation of multiple bands including p125fak and paxillin, and focal adhesion assembly in Swiss 3T3 cells. Top, quiescent cultures of Swiss 3T3 cells were treated in DMEM/Waymouth's medium (1:1, v/v) with 10 µg/ml bacterial lysate containing DNT for various times (0-24 h). Cells were lysed and the lysates were immunoprecipitated with anti-Tyr(P) 4G10 mAb. The immunoprecipitates were fractionated by SDS-PAGE and further analyzed by immunoblotting with p125fak (2A7 mAb) or paxillin (165 mAb). The results shown are representative autoradiographs of at least three independent experiments. Bottom, quiescent cultures of Swiss 3T3 cells were washed with DMEM and incubated in DMEM/Waymouth's medium (1:1, v/v) containing 10 µg/ml bacterial lysate containing DNT for the times indicated, and then washed with PBS, fixed in 3.7% paraformaldehyde, and permeabilized with 0.2% Triton X-100. Immunostaining with monoclonal anti-vinculin antibody demonstrates focal adhesions. A Cy3-conjugated rabbit anti-mouse IgG antibody was used to perform confocal imaging. Control bacterial lysate at 10 µg/ml neither induced tyrosine phosphorylation of p125fak and paxillin nor focal adhesion plaques at any of the time points examined (0-24 h, results not shown).
[View Larger Version of this Image (61K GIF file)]


Next, we tested whether the integrity of the cytoskeleton was necessary for DNT-stimulated tyrosine phosphorylation. As shown in Fig. 7, cytochalasin D or PDGF blocked DNT-stimulated stress fiber formation (data not shown), focal adhesion assembly (upper panel), and tyrosine phosphorylation of p125fak (middle panel). In addition, microinjection of C3 exoenzyme profoundly inhibited tyrosine phosphorylation of focal adhesion proteins in response to DNT (lower panel).


Fig. 7. Effect of cytochalasin D, PDGF, and C3 exoenzyme on DNT stimulated tyrosine phosphorylation and focal adhesion assembly. Upper panel, effect of cytochalasin D and PDGF on DNT-stimulated focal adhesion assembly. Cells were treated with: (A) 10 µg/ml control bacterial lysate (XL1-Blue) for 4 h, (B) 10 µg/ml bacterial lysate containing DNT for 4 h, (C) 1.2 µM cytochalasin D for 1 h and subsequently with 10 µg/ml bacterial lysate containing DNT for 4 h, or (D) 10 µg/ml bacterial lysate containing DNT for 4 h and 30 ng/ml PDGF for a further 10 min. Cells were then washed with PBS and fixed in 4% paraformaldehyde, permeabilized, and focal adhesion were then visualized with mouse anti-vinculin mAb and Cy3-conjugated rabbit anti-mouse IgG. Middle panel, effect of cytochalasin D and PDGF on DNT-stimulated p125fak tyrosine phosphorylation. Quiescent Swiss 3T3 cells were treated with (-) 10 µg/ml control bacterial lysate (XL1-Blue) or treated with 1.2 µM cytochalasin D (CYT.D) for 1 h and then incubated with 10 µg/ml bacterial lysate containing DNT for a further 4 h. Parallel cell cultures were treated with DNT for 4 h and subsequently with 30 ng/ml PDGF for a further 10 min. Cells were then lysed, and the lysates were further analyzed by immunoprecipitation using mAb 2A7 directed against p125fak followed by anti-Tyr(P) Western blotting. Lower panel, microinjection of the C3 exoenzyme prevents the increase of tyrosine phosphorylation of focal adhesion proteins. Quiescent cultures of Swiss 3T3 cells in 30-mm dishes were washed twice and incubated in DMEM/Waymouth's medium (1:1, v/v). Cells were microinjected with 0.5 mg/ml guinea pig IgG (A and B) or 0.5 mg/ml guinea pig IgG + 100 µg/ml C3 exoenzyme (C and D). Cells were then treated with 10 µg/ml bacterial lysate containing DNT. After 4 h of incubation, the cells were stained with 4G10 mAb directed against phosphotyrosine residues and visualized by confocal microscopy using Cy3-linked rabbit anti-mouse IgG (B and D). Microinjected cells (shown in A and B) were identified by staining with FITC-conjugated goat anti-guinea pig IgG Ab.
[View Larger Version of this Image (62K GIF file)]


CNF1 stimulates p125fak and paxillin tyrosine phosphorylation and stimulate DNA synthesis without promoting phospholipase C-mediated hydrolysis of PtdIns(4,5)P2 or PKC activation. As shown in Fig. 8, DNT failed to stimulate an increase in the phosphorylation of 80K/MARCKS or to promote a detectable increase in total inositol phosphate production. In addition, DNT, like CNF1, did not induce p42mapk activation. All these responses were induced by PMT in parallel cultures of Swiss 3T3 cells.


Fig. 8. DNT does not induce PKC activation, inositol phosphate production, or p42mapk activation. A, quiescent cells, labeled with 50 µCi/ml [32P]Pi for 18 h, were treated with 10 µg/ml control bacterial lysate (XL1-Blue), 10 µg/ml bacterial lysate containing DNT, 2 µg/ml control bacterial lysate (PC12), or 2 µg/ml bacterial lysate containing PMT and incubated for further 6 h. Cells were subsequently lysed and the extracts were immunoprecipitated with anti-80K/MARCKS antibody and further analyzed by SDS-PAGE. B, cells were prelabeled with 10 µCi/ml [2-3H]inositol for 16 h and 10 µg/ml control lysate (XL1-Blue), 10 µg/ml bacterial lysate containing DNT, 2 µg/ml control bacterial lysate (PC12), or 2 µg/ml bacterial lysate containing PMT was then added directly to the dishes and the cultures were incubated at 37 °C for 6 h. LiCl (20 mM) was then added, and after a further 30 min the cellular inositol phosphate content was determined. C, quiescent cells were treated for 4 h with 10 µg/ml control bacterial lysate (XL1-Blue), 10 µg/ml bacterial lysate containing DNT, 2 µg/ml control bacterial lysate (PC12), or 2 µg/ml bacterial lysate containing PMT and lysed, the lysates were subjected to SDS-PAGE, followed by Western blotting with anti-p42mapk antibody.
[View Larger Version of this Image (19K GIF file)]



DISCUSSION

The results presented here show for the first time that CNF1 and DNT, both intracellularly acting bacterial toxins, induce tyrosine phosphorylation of multiple substrates in Swiss 3T3 cells. In this study, we identified two substrates, p125fak and paxillin, which were tyrosine phosphorylated in response to CNF1 and DNT. A coordinate increase in tyrosine phosphorylation of p125fak and paxillin is induced by a variety of molecules that regulate cell growth and differentiation (6-9, 11-20, 22). Our results suggest that p125fak and paxillin tyrosine phosphorylation could also play a role in the signaling pathways stimulated by CNF1 and DNT.

Recent findings have raised the possibility that tyrosine phosphorylation of p125fak and paxillin, actin stress fiber formation, focal adhesion assembly, and p21rho function may lie in a novel signal transduction pathway (5, 22, 28, 30) that regulates cell motility and cell proliferation (24, 60). Here we used CNF1 and DNT to examine further the connections predicted by this pathway. We found that CNF1 and DNT stimulated tyrosine phosphorylation of p125fak and paxillin, actin stress fiber formation, and focal adhesion assembly with similar kinetics. Furthermore, pretreatment of quiescent Swiss 3T3 cells with cytochalasin D, at concentrations that completely disrupted the actin cytoskeleton and the focal adhesion plaques, abolished tyrosine phosphorylation of p125fak stimulated by both toxins. These results indicate that integrity of the cytoskeleton is essential for CNF1- and DNT-induced tyrosine phosphorylation. This conclusion was substantiated by experiments using PDGF at a high concentration (30 ng/ml), which disrupted actin stress fibers and focal adhesion assembly in response to CNF1 and DNT. At this concentration PDGF also profoundly decreased CNF1- and DNT-induced tyrosine phosphorylation of p125fak, revealing a novel cross-talk between these toxins and PDGF. Microinjection of C. botulinum C3 exoenzyme, which ADP-ribosylates and inactivates p21rho function, prevented tyrosine phosphorylation of focal adhesion proteins in response to either CNF1 or DNT. Thus, our results with CNF1 and DNT provide a novel line of evidence for the existence of a pathway in which p21rho is upstream of cytoskeletal reorganization and tyrosine phosphorylation of p125 and paxillin.

Most extracellular stimuli that promote actin reorganization and tyrosine phosphorylation of p125fak and paxillin also stimulate phospholipase C-mediated hydrolysis of PtdIns(4,5)P2 leading to Ins(1,4,5)P3-mediated Ca2+ mobilization and to the activation of diacylglycerol-dependent isoforms of PKC. Previous studies indicated that neither Ca2+ mobilization nor PKC activation mediate tyrosine phosphorylation of p125fak and paxillin in response to bombesin, lysophosphatidic acid, or PMT (6, 13, 22). However, activated phospholipase C not only generates Ins(1,4,5)P3 and diacylglycerol but also decreases PtdIns(4,5)P2 in the plasma membrane. PtdIns(4,5)P2 binds to several actin-binding proteins and vinculin (61-64) and thereby could modulate the organization of the actin cytoskeleton (65). In addition, p21rho activates phosphatidylinositol-4-phosphate-5-OH kinase and elevates PtdIns(4,5)P2 synthesis (66). These results raise the possibility that PtdIns(4,5)P2 turnover may play a role in promoting cytoskeletal reorganization and thus, tyrosine phosphorylation of p125fak and paxillin.

Our results demonstrate that CNF1 and DNT failed to stimulate the formation of inositol phosphates in Swiss 3T3 cells, suggesting that these toxins do not stimulate phospholipase C-mediated PtdIns(4,5)P2 hydrolysis. This conclusion was substantiated by the inability of CNF1 and DNT to deplete the Ins(1,4,5)P3-sensitive pool of Ca2+ and by the failure of these toxins to stimulate the phosphorylation of 80K/MARCKS, a prominent substrate of diacylglycerol-activated PKC isoforms expressed in Swiss 3T3 cells. In contrast, all these responses were induced by PMT in parallel cultures. Thus, our results demonstrate that p21rho-dependent actin cytoskeleton reorganization, focal adhesion assembly, and tyrosine phosphorylation of p125fak and paxillin can by dissociated from hydrolysis of PtdIns(4,5)P2 in CNF1- and DNT-treated Swiss 3T3 cells.

The findings presented here have another interesting implication. A wide range of extracellular signals including growth factors and mitogenic neuropeptides activate one or more members of the family of the highly conserved serine/threonine mitogen-activated protein (MAP) kinases (ERKs) (58, 59, 67). MAP kinases, important intermediates in signal transduction pathways leading to mitogenesis or differentiation, are activated predominantly via PKC in Swiss 3T3 cells stimulated by bombesin. Once activated p42mapk (ERK2) and p44mapk (ERK1) phosphorylate an array of cellular proteins including protein kinases, transcription factors, and proteins involved in the regulation of cell growth (68-71). Because CNF1 and DNT stimulate DNA synthesis in Swiss 3T3 cells, we investigated the ability of these toxins to induce activation of p42mapk and p44mapk. Our results demonstrated that unlike PMT, CNF1 and DNT did not stimulate p42mapk in these cells. These results suggest that CNF1 and DNT can signal entry into S phase without activating p42mapk and p44mapk in Swiss 3T3 cells.

The signaling events triggered by CNF and DNT appear to be very similar which suggest that both toxins trigger the same initial event, and indeed there is evidence that CNF and DNT each directly target and modify Rho (36, 37). CNF and DNT are homologous over a region of 100 amino acids near the C terminus (72) which in DNT but not in CNF contains a putative P-loop nucleotide-binding site. We have identified a lysine residue within this motif that is essential for the action of DNT, which suggests that the motif, and by inference this region, is involved in the catalytic function of DNT (51). Thus both CNF and DNT activate Rho but possibly through a different mechanism.

In conclusion, our results with CNF1 and DNT provide further evidence for a p21rho-dependent pathway leading to tyrosine phosphorylation of p125fak and paxillin. In particular, actin stress fiber formation, focal adhesion assembly, and tyrosine phosphorylation of p125fak were dissociated from PtdIns(4,5)P2 hydrolysis in CNF1- and DNT-treated cells. Furthermore, CNF1 and DNT induce DNA synthesis in the absence of detectable activation of p42mapk and p44mapk providing additional evidence for a novel p21rho-dependent signaling pathway that leads to entry into the S phase of the cell cycle.


FOOTNOTES

*   The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   Recipient of Research Fellowship from CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Brasilia, Brasil.
**   To whom all correspondence should be addressed. Tel.: 44-0171-269-3455; Fax: 44-0171-269-3417.
1   The abbreviations used are: PDGF, platelet-derived growth factor; PMT, Pasteurella multocida toxin; CNF, cytotoxic necrotizing factor; DNT, dermonecrotic toxin; anti-Tyr(P), anti-phosphotyrosine; DMEM, Dulbecco's modified Eagle's medium; mAb, monoclonal antibody; PBS, phosphate-buffered saline; p125fak, p125 focal adhesion kinase; PKC, protein kinase C; MAPK, mitogen-activated protein kinase; PAGE, polyacrylamide gel electrophoresis; Ins(1,4,5)P3, inositol 1,4,5-trisphosphate; PtdIns(4,5)P2, phosphatidylinositol 4,5-bisphosphate; FITC, fluorescein isothiocyanate; MARCKS, yristoylated lanine-ich -inase ubstrate.

ACKNOWLEDGEMENTS

We thank Drs. Toni Adams and Isobel Hoskin for production of bacterial lysates and Dr. Alfredo Caprioli for supplying the CNF1 clone.


REFERENCES

  1. Hanks, S. K., Calalb, M. B., Harper, M. C., and Patel, S. K. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 8487-8491 [Abstract]
  2. Schaller, M. D., Borgman, C. A., Cobb, B. S., Vines, R. R., Reynolds, A. B., and Parsons, J. T. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 5192-5196 [Abstract]
  3. Salgia, R., Li, J.-L., Lo, S. H., Brunkhorst, B., Kansas, G. S., Sobhany, E. S., Sun, Y., Pisick, E., Hallek, M., Ernst, T., Tantravahi, R., Chen, L. B., and Griffin, J. D. (1995) J. Biol. Chem. 270, 5039-5047 [Abstract/Free Full Text]
  4. Turner, C. E., and Miller, J. T. (1994) J. Cell Sci. 107, 1583-1591 [Abstract/Free Full Text]
  5. Rozengurt, E. (1995) Cancer Surveys 24, 81-96 [Medline] [Order article via Infotrieve]
  6. Zachary, I., Sinnett-Smith, J., and Rozengurt, E. (1992) J. Biol. Chem. 267, 19031-19034 [Abstract/Free Full Text]
  7. Sinnett-Smith, J., Zachary, I., Valverde, A. M., and Rozengurt, E. (1993) J. Biol. Chem. 268, 14261-14268 [Abstract/Free Full Text]
  8. Zachary, I., Sinnett-Smith, J., Turner, C. E., and Rozengurt, E. (1993) J. Biol. Chem. 268, 22060-22065 [Abstract/Free Full Text]
  9. Rankin, S., and Rozengurt, E. (1994) J. Biol. Chem. 269, 704-710 [Abstract/Free Full Text]
  10. Rankin, S., Hooshmand-Rad, R., Claesson-Welsh, L., and Rozengurt, E. (1996) J. Biol. Chem. 271, 7829-7834 [Abstract/Free Full Text]
  11. Kumagai, N., Morii, N., Fujisawa, K., Yoshimasa, T., Nakao, K., and Narumiya, S. (1993) FEBS Lett. 329, 273-276 [CrossRef][Medline] [Order article via Infotrieve]
  12. Hordijk, P. L., Verlaan, I., van Corven, E. J., and Moolenaar, W. H. (1994) J. Biol. Chem. 269, 645-651 [Abstract/Free Full Text]
  13. Seufferlein, T., and Rozengurt, E. (1994) J. Biol. Chem. 269, 9345-9351 [Abstract/Free Full Text]
  14. Seufferlein, T., and Rozengurt, E. (1994) J. Biol. Chem. 269, 27610-27617 [Abstract/Free Full Text]
  15. Seufferlein, T., and Rozengurt, E. (1995) J. Biol. Chem. 270, 1-9 [Free Full Text]
  16. Kornberg, L., Earp, H. S., Parsons, J. T., Schaller, M., and Juliano, R. L. (1992) J. Biol. Chem. 267, 23439-23442 [Abstract/Free Full Text]
  17. Guan, J. L., and Shalloway, D. (1992) Nature 358, 690-692 [CrossRef][Medline] [Order article via Infotrieve]
  18. Burridge, K., Turner, C. E., and Romer, L. H. (1992) J. Cell Biol. 119, 893-903 [Abstract]
  19. Lipfert, L., Haimovich, B., Schaller, M. D., Cobb, B. S., Parsons, J. T., and Brugge, J. S. (1992) J. Cell Biol. 119, 905-912 [Abstract]
  20. Vuori, K., and Ruoslahti, E. (1993) J. Biol. Chem. 268, 21459-21462 [Abstract/Free Full Text]
  21. Kanner, S. B., Reynolds, A. B., Vines, R. R., and Parsons, J. T. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 3328-3332 [Abstract]
  22. Lacerda, H. M., Lax, A. J., and Rozengurt, E. (1996) J. Biol. Chem. 271, 439-445 [Abstract/Free Full Text]
  23. Schaller, M. D., and Parsons, J. T. (1995) Mol. Cell. Biol. 15, 2635-2645 [Abstract]
  24. Ilic, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, J., Nomura, S., Fujimoto, J., Okada, M., Yamamoto, T., and Aizawa, S. (1995) Nature 377, 539-544 [CrossRef][Medline] [Order article via Infotrieve]
  25. Ridley, A. J., and Hall, A. (1992) Cell 70, 389-399 [Medline] [Order article via Infotrieve]
  26. Hynes, R. O. (1992) Cell 69, 11-25 [Medline] [Order article via Infotrieve]
  27. Turner, C. E. (1991) J. Cell Biol. 115, 201-207 [Abstract]
  28. Rankin, S., Morii, N., Narumiya, S., and Rozengurt, E. (1994) FEBS Lett. 354, 315-319 [CrossRef][Medline] [Order article via Infotrieve]
  29. Kumagai, N., Morii, N., Fujisawa, K., Nemoto, Y., and Narumiya, S. (1993) J. Biol. Chem. 268, 24535-24538 [Abstract/Free Full Text]
  30. Seckl, M. J., Morii, N., Narumiya, S., and Rozengurt, E. (1995) J. Biol. Chem. 270, 6984-6990 [Abstract/Free Full Text]
  31. Aktories, K., Braun, U., Habermann, B., and Rosener, S. (1990) in ADP-ribosylating Toxins and G Proteins: Insights into Signal Transduction (Moss, J., and Vaughn, M., eds), pp. 97-115, American Society for Microbiology, Washington, D. C.
  32. Just, I., Wilm, M., Selzer, J., Rex, G., von Eichel-Streiber, C., Mann, M., and Aktories, K. (1995) J. Biol. Chem. 270, 13932-13936 [Abstract/Free Full Text]
  33. Just, I., Selzer, J., Wilm, M., von Eichel-Streiber, C., Mann, M., and Aktories, K. (1995) Nature 375, 500-503 [CrossRef][Medline] [Order article via Infotrieve]
  34. Falbo, V., Pace, T., Picci, L., Pizzi, E., and Caprioli, A. (1993) Infect. Immun. 61, 4909-4914 [Abstract]
  35. Horiguchi, Y., Nakai, T., and Kume, K. (1989) Microbiol. Pathogens 6, 361-368 [Medline] [Order article via Infotrieve]
  36. Oswald, E., Sugai, M., Labigne, A., Wu, W., Fiorentini, C., Boquet, P., and O'Brien, A. D. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 3814-3818 [Abstract]
  37. Horiguchi, Y., Senda, T., Sugimoto, N., Katahira, J., and Matsuda, M. (1995) J. Cell Sci. 108, 3243-3251 [Abstract/Free Full Text]
  38. Caprioli, A., Falbo, V., Roda, L. G., Ruggeri, F. M., and Zona, C. (1983) Infect. Immun. 39, 1300-1306 [Medline] [Order article via Infotrieve]
  39. Caprioli, A., Donelli, G., Falbo, V., Possenti, R., and Roda, L. G. (1984) Biochem. Biophys. Res. Commun. 118, 587-593 [Medline] [Order article via Infotrieve]
  40. Horiguchi, Y., Sugimoto, N., and Matsuda, M. (1993) Infect. Immun. 61, 3611-3615 [Abstract]
  41. Rozengurt, E., and Sinnett-Smith, J. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 2936-2940 [Abstract]
  42. Herget, T., Brooks, S. F., Broad, S., and Rozengurt, H. (1993) Proc. Natl. Acad. Sci U. S. A. 909, 2945-2949
  43. Kamps, M. P., and Sefton, B. M. (1989) Anal. Biochem. 176, 22-27 [Medline] [Order article via Infotrieve]
  44. Erusalimsky, J. D., Brooks, S. F., Herget, T., Morris, C., and Rozengurt, E. (1991) J. Biol. Chem. 266, 7073-7080 [Abstract/Free Full Text]
  45. Berridge, M. J., Dawson, R. M. C., Downes, C. P., Heslop, J. P., and Irvine, R. F. (1983) Biochem. J. 212, 473-482 [Medline] [Order article via Infotrieve]
  46. Grynkiewicz, G., Poenie, M., and Tsien, R. Y. (1985) J. Biol. Chem. 260, 3440-3450 [Abstract]
  47. Lopez-Rivas, A., Mendoza, S. A., Nanberg, E., Sinnett-Smith, J., and Rozengurt, E. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 5768-5772 [Abstract]
  48. Nanberg, E., and Rozengurt, E. (1988) EMBO J. 7, 2741-2747 [Abstract]
  49. Tsien, R. Y., Pozzan, T., and Rink, T. J. (1982) J. Cell Biol. 94, 325-334 [Abstract]
  50. Leevers, S. J., and Marshall, C. J. (1992) EMBO J. 11, 569-574 [Abstract]
  51. Pullinger, G. D., Adams, T. E., Mullan, P. B., Garrod, T. I., and Lax, A. J. (1996) Infect. Immun. 64, 4163-4171 [Abstract]
  52. Fiorentini, C., Donelli, G., Matarrese, P., Fabbri, A., Paradisi, S., and Boquet, P. (1995) Infect. Immun. 63, 3936-3944 [Abstract]
  53. Nemoto, Y., Namba, T., Kozaki, S., and Narumiya, S. (1991) J. Biol. Chem. 266, 19312-19319 [Abstract/Free Full Text]
  54. Aktories, K., Weller, U., and Chatwal, G. S. (1987) FEBS Lett. 212, 109-113 [CrossRef][Medline] [Order article via Infotrieve]
  55. Sekine, A., Fujiwara, M., and Narumiya, S. (1989) J. Biol. Chem. 264, 8602-8605 [Abstract/Free Full Text]
  56. Staddon, J. M., Chanter, N., Lax, A. J., Higgins, T. E., and Rozengurt, E. (1990) J. Biol. Chem. 265, 11841-11848 [Abstract/Free Full Text]
  57. Staddon, J. M., Barker, C. J., Murphy, A. C., Chanter, N., Lax, A. J., Michell, R. H., and Rozengurt, E. (1991) J. Biol. Chem. 266, 4840-4847 [Abstract/Free Full Text]
  58. Pelech, S. L., and Sanghera, J. S. (1992) Science 257, 1355-1356 [Medline] [Order article via Infotrieve]
  59. Posada, J., and Cooper, J. A. (1992) Mol. Biol. Cell 3, 383-392
  60. Gilmore, A. P., and Romer, L. H. (1996) Mol. Biol. Cell 7, 1209-1224 [Abstract]
  61. Lee, S. B., and Rhee, S. G. (1995) Curr. Opin. Cell Biol. 7, 183-189 [CrossRef][Medline] [Order article via Infotrieve]
  62. Lassing, I., and Lindberg, U. (1985) Nature 314, 472-474 [Medline] [Order article via Infotrieve]
  63. Janmey, P. A., and Stossel, T. P. (1987) Nature 325, 362-364 [CrossRef][Medline] [Order article via Infotrieve]
  64. Fukami, K. (1992) Nature 359, 150-152 [CrossRef][Medline] [Order article via Infotrieve]
  65. Gilmore, A. P., and Burridge, K. (1996) Nature 381, 531-535 [CrossRef][Medline] [Order article via Infotrieve]
  66. Chong, L. D., Traynor-Kaplan, A., Bokoch, G. M., and Schwartz, M. A. (1994) Cell 79,
  67. Cobb, M., Boulton, T. G., and Robbins, D. J. (1991) Mol. Biol. Cell 2, 965-968
  68. Sturgill, T. W., and Wu, J. (1991) Biochim. Biophys. Acta 1092, 350-357 [Medline] [Order article via Infotrieve]
  69. Gille, H., Sharrock, A. D., and Shaw, P. E. (1992) Nature 358, 414-417 [CrossRef][Medline] [Order article via Infotrieve]
  70. Seth, A., Alvarez, E., Gupta, S., and Davis, R. J. (1991) J. Biol. Chem. 266, 23521-23524 [Abstract/Free Full Text]
  71. Lin, L.-L., Wartman, M., Lin, Y. A., Knopf, J. L., Seth, A., and Davies, R. J. (1993) Cell 72, 269-278 [Medline] [Order article via Infotrieve]
  72. Walker, K. E., and Weiss, A. A. (1994) Infect Immun 62, 3817-3828 [Abstract]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.